Casatest brain 367

A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death

Por um escritor misterioso
Last updated 23 outubro 2024
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
Various Protein Kinase Inhibitors as Anticancer Agents
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
PDF) The solute carrier SLC35F2 enables YM155-mediated DNA damage
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
The solute carrier SLC35F2 enables YM155-mediated DNA damage
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
Future Pharmacology, Free Full-Text
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
Nanoparticle-mediated inhibition of survivin to overcome drug
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
The DNA Double-Strand Break Repair in Glioma: Molecular Players
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
Targeted therapy for non‐small‐cell lung cancer: New insights into
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting
Recomendado para você
você pode gostar

© 2014-2024 chuaphuocthanh.kiengiang.vn. All rights reserved.